Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Avricore Health Inc (AVCR)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.1500 0.0000    0.00%
02/05 - Delayed Data. Currency in CAD ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 0.1500 / 0.1600
  • Day's Range: 0.1500 - 0.1550
Type:  Equity
Market:  Canada
Avricore Health 0.1500 0.0000 0.00%

AVCR Recent Sentiments

 
User's sentiments regarding Avricore Health shares are displayed on both charts showing different time periods and in a detailed table.

Assess users' predictions on whether they expect AVCR shares to be bearish or bullish and add your investment views to the bearish or bullish futures discussion for Avricore Health.
Start Date Username Call Open Rate End Date Chg. %
Feb 02, 2024 Osman Ulas Aktas   0.1650 Feb 23, 2024 @ 0.1400 +15.15%
Apr 10, 2023 DN MAC   0.2850 Apr 17, 2023 @ 0.2800 -1.75%
Dec 20, 2021 Tyler Stevens   0.1400 Jan 14, 2022 @ 0.1600 +14.29%
Apr 26, 2021 david farnfield   0.2650 May 21, 2021 @ 0.2000 -24.53%
Feb 26, 2021 peter parsons   0.3000 Mar 11, 2021 @ 0.3150 +5.00%
Feb 19, 2021 Francis Bourget   0.4550 Mar 02, 2021 @ 0.2750 -39.56%
Feb 19, 2021 Velo Relaxing and...   0.4650 Feb 25, 2021 @ 0.3700 -20.43%
Feb 10, 2021 Parin Patel   0.5200 Mar 05, 2021 @ 0.2300 -55.77%
Feb 09, 2021 Malhaarsinh Solanki   0.5400 Mar 05, 2021 @ 0.2300 -57.41%
Feb 09, 2021 Malhaarsinh Solanki   0.5400 Mar 05, 2021 @ 0.2300 -57.41%
Feb 09, 2021 Malhaarsinh Solanki   0.5400 Mar 05, 2021 @ 0.2300 -57.41%
Feb 09, 2021 Malhaarsinh Solanki   0.5400 Mar 05, 2021 @ 0.2300 -57.41%
Feb 09, 2021 Malhaarsinh Solanki   0.5400 Mar 05, 2021 @ 0.2300 -57.41%
Feb 09, 2021 Kurt Barnett   0.6200 Mar 05, 2021 @ 0.2300 -62.90%
Feb 08, 2021 Askar Danial   0.4900 Mar 05, 2021 @ 0.2300 +53.06%
Feb 04, 2021 david farnfield   0.3350 Feb 26, 2021 @ 0.2950 -11.94%
Feb 01, 2021 Shirly Chan   0.2400 Feb 26, 2021 @ 0.2950 +22.92%
Jan 29, 2021 Nico Arseneault   0.2400 Feb 09, 2021 @ 0.5300 +120.83%
Jan 26, 2021 Shirly Chan   0.2200 Jan 29, 2021 @ 0.1950 -11.36%
Jan 26, 2021 Nico Arseneault   0.2200 Jan 28, 2021 @ 0.1950 -11.36%
Jan 26, 2021 Nico Arseneault   0.2200 Jan 28, 2021 @ 0.1950 -11.36%
Oct 06, 2020 Far Kamalov   0.1150 Oct 30, 2020 @ 0.0800 -30.43%
Sep 30, 2020 Mohammed Dughaish   0.1400 Oct 23, 2020 @ 0.0900 -35.71%
Sep 11, 2020 Far Kamalov   0.0500 Oct 02, 2020 @ 0.1400 +180.00%
Sep 10, 2020 rana birk   0.0500 Oct 02, 2020 @ 0.1400 +180.00%
Sep 09, 2020 Ronald Favis   0.0500 Oct 02, 2020 @ 0.1400 +180.00%
Sep 09, 2020 Alexandre Pineault   0.0550 Oct 02, 2020 @ 0.1400 +154.55%
Apr 16, 2020 Ling Li   0.0150 May 08, 2020 @ 0.0300 +100.00%
Sep 06, 2019 Lydian User   0.0300 Sep 27, 2019 @ 0.0250 -16.67%
May 10, 2019 samuel Landry   0.1100 May 31, 2019 @ 0.0700 -36.36%
Oct 23, 2018 Mike Dean   0.1350 Nov 22, 2018 @ 0.1950 +44.44%
Aug 01, 2018 Vicky Barsanti   0.1500 Aug 31, 2018 @ 0.1400 -6.67%
May 31, 2018 Anthony Stal   0.1950 Jun 30, 2018 @ 0.1800 +7.69%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AVCR Price Commentary

Write your thoughts about Avricore Health Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email